Universe Pharmaceuticals (UPC) Short-term Investments (2021 - 2024)

Universe Pharmaceuticals has disclosed Short-term Investments across 4 years of filings, most recently posting $1.4 billion for Q3 2024.

• Short-term Investments for Q3 2024 came in at $1.4 billion, up 100691.56% year-over-year; the trailing twelve-month figure through Sep 2024 was $1.4 billion (up 100691.56% YoY), and the FY2024 annual result was $1.4 billion, up 100691.56% from the prior year.
• Short-term Investments came in at $1.4 billion for Q3 2024 at Universe Pharmaceuticals, up from $2.5 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.4 billion in Q3 2024 to a low of $1.4 million in Q3 2023.
• The 4-year median for Short-term Investments is $13.3 million (2023), against an average of $205.2 million.
• Across the five-year window, Short-term Investments plunged 89.6% in 2023 and surged 100691.56% in 2024, its largest moves.
• Universe Pharmaceuticals' Short-term Investments stood at $13.7 million in 2021, then dropped by 4.2% to $13.1 million in 2022, then slumped by 89.6% to $1.4 million in 2023, then soared by 100691.56% to $1.4 billion in 2024.
• The last three Short-term Investments figures came in at $1.4 billion (Q3 2024), $2.5 million (Q1 2024), and $1.4 million (Q3 2023), per Business Quant data.